Stay updated on Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial
Sign up to get notified when there's something new on the Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial page.

Latest updates to the Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov record for the cannabidiol extension study in people with Dravet or Lennox-Gastaut syndrome is available, with detailed study information and links to publications and supporting documents.SummaryDifference69%

- Check15 days agoChange DetectedThe footer version label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA notice was added about NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434, with links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer’s site revision label was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, signifying that access to the record is blocked.SummaryDifference22%

Stay in the know with updates to Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial page.